- Mursla Bio’s platform for surveillance of liver cancer receives FDA approval
- Hansa Biopharma appoints Renée Aguiar-Lucander as CEO
- Neurizon makes appointments to executive team
- ViroCell and UCL launch trial to treat childhood leukaemia relapse
- Dual immunotherapy for bowel cancer now available under NHS
- CARBOGEN AMCIS manufacturing license advances services in China
- AOTI diabetic foot care therapy to be used by NHS
- Galapagos announces leadership changes amid planned company split
- Kidney Research UK backs digital innovation to support 15 million patients with long-term conditions
- Meribel Pharma Solutions launches to take pharma services to new heights
- Allegro confirms successful safety testing of osteoarthritis treatment
- Johnson & Johnson announces successful results from trial for myeloma treatment
- Astraveus expands leadership team ahead of Lakhesys launch
- Moderna authorised to upscale development of mRNA vaccines in UK
- ProQR appoints new CFO and CMO to drive clinical-stage growth